This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

Sanofi’s vision for Better Care for Rare: a world where diagnosis, treatment and support for rare diseases is equitable and accessible, where the chance to live well with a rare disease has no exception, no matter who people are or where they are in their journey.

We, at Sanofi, hope to fulfil this vision through close alignment with the England Rare Diseases Action Plans in order to help solve the complex and unique challenges inherent in rare diseases. 

Hear from experts on the future of rare diseases, including their thoughts and opinions on how clinical practice and services need to change to fulfil the priorities set out in the Rare Disease Framework. 

Antonio Ochoa-Ferraro

Specialist Pharmacist in Inherited Metabolic Disease

Dr Alex Broomfield

Consultant in Inherited Metabolic Diseases at GOSH

Dr Karolina Stepien

Consultant in Metabolic Medicine at Salford Royal Hospital

1/3

Antonio Ochoa-Ferraro

Specialist Pharmacist in Inherited Metabolic Disease

Dr Alex Broomfield

Consultant in Inherited Metabolic Diseases at GOSH

Dr Karolina Stepien

Consultant in Metabolic Medicine at Salford Royal Hospital

MAT-XU-2300007 (v3.0) Date of preparation: October 2023